Global Regenerative Medicine Market is Estimated to Value Over USD 39.1 Billion by 2026 End

  • 02 Oct 2019

Global Regenerative Medicine Market is estimated to value over USD 39.1 billion by 2026 end and register a CAGR of over 22.7% during the forecast period 2019 to 2026.


The global regenerative medicine market growth is primarily steered by increasing incidences of genetic disorders and persistent diseases and rise in the investments made by the government in the research activities for regenerative medicine. Furthermore, the factors driving the market growth include the untapped potential of nanotechnology the emergence of stem cell technology, increase in the incidence of trauma injuries and persistent diseases, a dearth of organs for transplantation technological advancements in surgical procedures and monitoring devices and rising prevalence of degenerative diseases.


The therapeutics segment incurred the largest global regenerative medicine market share in 2018 and is predicted to continue its subjugation during the forecast period. The primary cell-based therapy is the most developed and novel therapeutics available owing to their early adoption in clinical applications and their use for a variety of indications.

Progenitor cell and stem cell-based therapies are predicted to record the fastest growth rate over the forecast period owing to massive investments in research activities related to stem cells along with reworking the policies initiated by the government for their usage in various clinical applications. The allogeneic stem cell-based therapies are projected to account for the largest market share while the autologous therapies are predicted to exhibit a significant growth rate during the forecast time frame.

The North American region holds the largest market share with respect to the generation of revenue owing to the prevalence of a substantial number of major players that are based in the U.S. Furthermore, the presence of research institutes involved in development of advanced therapeutics and the availability of novel technologies can be the factors responsible for the prevalence of clinical trials to escalate in the region.

Key market players included in the global regenerative medicine industry are Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Spark Therapeutics, Osiris Therapeutics, Kite Pharma, Organogenesis.


Global Regenerative Medicine Market Segmentation:

By Type

  • Cell-Based Immunotherapy & Cell Therapy Products
  • Allogeneic Products
  • Autologous Products
  • Tissue-Engineered Products
  • Gene Therapy Products


By Application

  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes
  • Other Applications


By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World


FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth


Objectives of the Study:

  • To provide with an exhaustive analysis on the global regenerative medicine market by type, by application and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact